| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5656376 | HPB | 2017 | 4 Pages |
Abstract
A significant percentage of patients with T1b/T2 disease have identifiable residual disease following second surgery. Residual disease is associated with poor survival. It is therefore important to inform patients that completion cholecystectomy is primarily performed to inform staging rather than to improve prognosis.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Henry Watson, Bobby Dasari, Judy Wyatt, Ernest Hidalgo, Raj Prasad, Peter Lodge, Giles Toogood,